These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11351953)

  • 1. Radiotherapy for Graves' ophthalmopathy: current treatment recommendations.
    McDougall IR; Donaldson SS
    Front Radiat Ther Oncol; 2001; 35():57-64. PubMed ID: 11351953
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of radiotherapy in Graves' ophthalmopathy].
    Jaulerry C
    J Fr Ophtalmol; 2004 Sep; 27(7):825-7. PubMed ID: 15499286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy for Graves' ophthalmopathy].
    Kuhnt T; Müller AC; Janich M; Gerlach R; Hädecke J; Duncker GI; Dunst J
    Klin Monbl Augenheilkd; 2004 Nov; 221(11):915-21. PubMed ID: 15562354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of radiation therapy in Graves' ophthalmopathy.
    Chowdhury AD; Moriarty MJ
    Australas Radiol; 1996 Nov; 40(4):422-3. PubMed ID: 8996904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience of radiation therapy for Graves' ophthalmopathy.
    Takahashi T; Mitsuhashi N; Nagashima H; Sakurai H; Murata O; Ishizeki K; Shimaya S; Hayakawa K; Niibe H
    Radiat Med; 1996; 14(6):343-7. PubMed ID: 9132818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?
    Bartalena L; Marcocci C; Gorman CA; Wiersinga WM; Pinchera A
    J Endocrinol Invest; 2003 Jan; 26(1):5-16. PubMed ID: 12602528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aftermath of orbital radiotherapy for graves' ophthalmopathy.
    Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Buettner H; Robertson DM; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
    Ophthalmology; 2002 Nov; 109(11):2100-7. PubMed ID: 12414422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters.
    Gerding MN; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2000 May; 52(5):641-6. PubMed ID: 10792345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Manetti L; Tanda ML; Dell'Unto E; Rocchi R; Cartei F; Pinchera A
    Thyroid; 1998 May; 8(5):439-41. PubMed ID: 9623740
    [No Abstract]   [Full Text] [Related]  

  • 10. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Tanda ML; Rocchi R; Mazzi B; Barbesino G; Pinchera A
    Thyroid; 2002 Mar; 12(3):245-50. PubMed ID: 11952048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy.
    Wartofsky L
    J Clin Endocrinol Metab; 1995 Feb; 80(2):347-9. PubMed ID: 7852488
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
    DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C]
    J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.
    Broerse JJ; Snijders-Keilholz A; Jansen JT; Zoetelief J; Klein C; Seegenschmiedt MH
    Radiother Oncol; 1999 Dec; 53(3):205-8. PubMed ID: 10660199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating severe Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Pinchera A
    Baillieres Clin Endocrinol Metab; 1997 Oct; 11(3):521-36. PubMed ID: 9532337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but...
    Pinchera A; Bartalena L; Marcocci C
    J Clin Endocrinol Metab; 1995 Feb; 80(2):342-5. PubMed ID: 7852486
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation and Graves' ophthalmopathy.
    Orcutt JC; Kinyoun JL
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2543. PubMed ID: 7677916
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of independent collimation in the treatment of Graves' ophthalmopathy.
    Snow A
    Br J Radiol; 1999 Apr; 72(856):389-91. PubMed ID: 10474501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital radiotherapy for Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Pinchera A
    J Clin Endocrinol Metab; 2004 Jan; 89(1):13-4. PubMed ID: 14715819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Graves' ophthalmopathy with irradiation].
    Slampa P; Spurný V; Seneklová Z; Krákorová D
    Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.